DOUBLE-BLIND COMPARISON OF THE EFFECTS OF LONG-TERM TREATMENT WITH DOXAZOSIN OR ATENOLOL ON SERUM-LIPOPROTEINS

被引：51
作者：
LEHTONEN, A [1 ]
HIMANEN, P [1 ]
SARASTE, M [1 ]
NIITTYMAKI, K [1 ]
MARNIEMI, J [1 ]
机构：
[1] SOCIAL INSURANCE INST, REHABIL RES CTR, SF-20700 TURK, FINLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷
关键词：
D O I：
10.1111/j.1365-2125.1986.tb02857.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S77 / S81
页数：5
相关论文
共 20 条
[1]  
AMES RP, 1976, LANCET, V1, P721
[2]  
BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[3]   METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J].
DAY, JL ;
SIMPSON, N ;
METCALFE, J ;
PAGE, RL .
BRITISH MEDICAL JOURNAL, 1979, 1 (6156) :77-80
[4]   DISCRIMINATIVE VALUE OF LIPIDS AND APOPROTEINS IN CORONARY HEART-DISEASE [J].
DEBACKER, G ;
ROSSENEU, M ;
DESLYPERE, JP .
ATHEROSCLEROSIS, 1982, 42 (2-3) :197-203
[5]   THE EFFECT OF METOPROLOL AND ATENOLOL ON PLASMA HIGH-DENSITY LIPOPROTEIN LEVELS IN MAN [J].
ENGLAND, JDF ;
SIMONS, LA ;
GIBSON, JC ;
CARLTON, M .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (03) :329-333
[6]   A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
FRICK, MH ;
HALTTUNEN, P ;
HIMANEN, P ;
HUTTUNEN, M ;
PORSTI, P ;
PITKAJARVI, T ;
POYHONEN, L ;
PYYKONEN, ML ;
REINIKAINEN, P ;
SALMELA, P ;
SARASTE, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S55-S62
[7]  
GIDEZ LI, 1982, J LIPID RES, V23, P1206
[8]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[9]   HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ANTIHYPERTENSIVE DRUGS - OSLO STUDY [J].
HELGELAND, A ;
HJERMANN, I ;
LEREN, P ;
ENGER, S ;
HOLME, I .
BRITISH MEDICAL JOURNAL, 1978, 2 (6134) :403-403
[10]   EFFECT OF PINDOLOL ON SERUM-LIPIDS AND LIPID METABOLIZING ENZYMES [J].
LEHTONEN, A ;
HIETANEN, E ;
MARNIEMI, J ;
PELTONEN, P ;
NISKANEN, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S445-S448
12